Acticor Biotech Financials
| ALACT Stock | EUR 0.25 0.00 0.00% |
Acticor |
Understanding current and past Acticor Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acticor Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Acticor Biotech's assets may result in an increase in income on the income statement.
Acticor Biotech Stock Summary
Acticor Biotech competes with Hoteles Bestprice, Jacquet Metal, BEBO Health, Sidetrade, and Metalliance. Acticor Biotech SAS, a clinical stage biopharmaceutical company, develops drugs for the treatment of acute phase of thrombotic diseases. The company was founded in 2013 and is headquartered in Paris, France. ACTIPLAY is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0014005OJ5 |
| Business Address | Btiment Inserm U1148, |
| Sector | Media |
| Industry | Communication Services |
| Benchmark | Dow Jones Industrial |
| Website | acticor-biotech.com |
| Phone | 33 9 70 46 86 40 |
| Currency | EUR - Euro |
You should never invest in Acticor Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Acticor Stock, because this is throwing your money away. Analyzing the key information contained in Acticor Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Acticor Biotech Key Financial Ratios
Acticor Biotech's financial ratios allow both analysts and investors to convert raw data from Acticor Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Acticor Biotech over time and compare it to other companies across industries.Acticor Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acticor Biotech's current stock value. Our valuation model uses many indicators to compare Acticor Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acticor Biotech competition to find correlations between indicators driving Acticor Biotech's intrinsic value. More Info.Acticor Biotech SAS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acticor Biotech's earnings, one of the primary drivers of an investment's value.Acticor Biotech SAS Systematic Risk
Acticor Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Acticor Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Acticor Biotech SAS correlated with the market. If Beta is less than 0 Acticor Biotech generally moves in the opposite direction as compared to the market. If Acticor Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Acticor Biotech SAS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Acticor Biotech is generally in the same direction as the market. If Beta > 1 Acticor Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Acticor Biotech Thematic Clasifications
Acticor Biotech SAS is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Acticor Biotech February 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Acticor Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Acticor Biotech SAS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Acticor Biotech SAS based on widely used predictive technical indicators. In general, we focus on analyzing Acticor Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Acticor Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 14.3 | |||
| Value At Risk | (5.71) | |||
| Potential Upside | 2.94 |
Additional Tools for Acticor Stock Analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.